Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Regeneron Pharmaceuticals, Inc. (NQ: REGN)
242.76 USD  +10.05 (+4.32%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Regeneron Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
5 Undervalued Stocks Flying Under The Radar!
Today 12:25 EDT
Hilary Joy Kramer, Chief Market Strategist, GameChangerStocks.com Read More
category NASDAQ:MEIP , NASDAQ:REGN , NASDAQ:ICPT , and 2 more.
from Forbes Real Time
Jefferies Says Analysis on Elan Supports $19/Share Takeover Bid, Lifts Price Target to $19
Today 10:39 EDT
In a report from Jefferies' Corey Davis published Tuesday, the analyst suggested Elan (NYSE: ELN ) execs have indicated they may agree or strongly consider a takeover anywhere between $15 to $20 per... Read More
category ELN , Benzinga , REGN , and 11 more.
from Latest Articles from Benzinga.com
Elan Corp (ELN) Could Be Worth $19 in a Takeout - Jefferies
Today 7:11 EDT
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8425504 for the full story. Read More
from StreetInsider.com News Articles
A Growth Investor Who Smartly Balances Blue Chips And Biotech
June 13, 2013
This is one of a series of blog posts from the Morningstar Investment Conference in Chicago. Read More
category NASDAQ:GOOG , NYSE:WMT , NASDAQ:CRM , and 2 more.
from Forbes Real Time
Bio-Wire Equity Surveillance – Closing Bell 6/12/2013
June 12, 2013
Wednesday, June 12th, 2013 DJIA: -.84% to 14,995.23 S&P 500: -.84% to 1,612.52 NASDAQ: -1.06% to 3,400.43 NYSE Arca – Pharma Index: -.06% to 425.42 Big pharma (Mkt Cap $10 B+) -.89% Mid-sized pharma... Read More
category REGN , QCOR , TEVA , and 4 more.
from Bio-Wire.Com
Short Interest Falls in Vertex, Rises in Biogen Idec (VRTX, BIIB)
June 12, 2013
Among biotech and emerging pharmaceutical companies, Biogen Idec (NASDAQ: BIIB ), saw the most significant rise in short interest between the May 15 and May 31 settlement dates. The number of shares... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 35 more.
from Latest Articles from Benzinga.com
Notable ETF Outflow Detected - IBB, REGN, AMGN, CELG
June 12, 2013
Symbols mentioned in this story: IBB, REGN, AMGN, CELG Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... Read More
category ETFs
from ETF Channel
Market Wrap for Thursday, June 6: Stocks Reverse Mid-Day; Rally to Close at Session Highs
June 06, 2013
The U.S. stock market surged on Thursday after an afternoon rally lifted the major averages out of negative territory. Stocks closed near their best levels of the session, with the Dow adding around 80... Read More
category Earnings , Benzinga , REGN , and 28 more.
from Latest Articles from Benzinga.com
Bio-Wire Equity Surveillance – Closing Bell 6/6/2013
June 06, 2013
Thursday, June 6th, 2013 Overview Today was bullish (after a reversal) for the broader market with the Dow moving +.53% to 15,041, the S&P 500 moving +.57% to 1618 and the NASDAQ moving +.66% to 3424.... Read More
category REGN , ENDP , MNTA , and 3 more.
from Bio-Wire.Com
Regeneron (REGN) Continues Higher on Positive EYLEA Phase 3 Data
June 06, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8397504 for the full story. Read More
from StreetInsider.com News Articles
OPKO Looks Lucrative as Acquired hGH-CTP Moves Into Phase III Trials
June 06, 2013
OPKO Health (NASDAQ: OPK) has been seeing a steady rise in short interest throughout the last few months – with the last measurement by NASDAQ coming in at 30.16 M shares on May 15th 2013 as... Read More
category RXII , OPK , TSRO , and 1 more.
from Bio-Wire.Com
Bayer say VEGF Trap-Eye shows promise as mCNV treatment
June 06, 2013
FRANKFURT, June 6 (Reuters) - Bayer said on Thursday its drug VEGF Trap-Eye had demonstrated to improve visual acuity in a late-stage trial on patients suffering from myopic choroidal... Read More
category companyNews
from Reuters: Company News
Two More Weekly LCD Sell Signals
June 05, 2013
The US stock market failed to continue higher after Monday's rebound, and once again, the overseas markets are putting pressure on US stocks in early trading Wednesday. The Nikkei 225 was hit hard... Read More
category NASDAQ:IBB , NASDAQ:SPY , NYSE:XLV , and 2 more.
from Forbes Real Time
IBB, REGN, AMGN, CELG: Large Outflows Detected at ETF
June 04, 2013
Symbols mentioned in this story: IBB, REGN, AMGN, CELG Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... Read More
category ETFs
from ETF Channel
Cramer: Out with the New, In with the Old
June 03, 2013
What the heck is happening in the stock market? It seems there's some sort of rotation underway, but it's not a rotation in any conventional sense. Read More
category Regeneron Pharmaceuticals Inc , Yelp , Merck & Co Inc , and 23 more.
from CNBC.com News
New drugs trail many old ones in effectiveness against disease
June 03, 2013
NEW YORK, June 3 (Reuters) - Despite the more than $50 billion that U.S. pharmaceutical companies have spent every year since the mid-2000s to discover new medications, drugmakers have barely improved... Read More
category companyNews
from Reuters: Company News
3 ways to play the biotech boom
June 03, 2013
If you want to join in the biotech boom, these funds offer varying levels of risk and protection, writes Jeff Reeves. Read More
category REGN , Biotechnology , Opinion , and 24 more.
from MarketWatch
UK cost agency recommends Bayer, Regeneron eye drug
May 30, 2013
LONDON, May 31 (Reuters) - Britain's healthcare cost watchdog NICE is recommending a new eye drug from Bayer and Regeneron, after a price discount was offered for its use on the state health service. Read More
category companyNews
from Reuters: Company News
Short Interest in Vertex Rises, in Biogen Idec Falls
May 29, 2013
Among biotech and emerging pharmaceutical companies, Regeneron Pharmaceuticals (NASDAQ: REGN ) and Vertex Pharmaceuticals (NASDAQ: VRTX ) saw he most significant rise in short interest between the... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 36 more.
from Latest Articles from Benzinga.com
Agree To Buy Regeneron Pharmaceuticals, Inc. At $165, Earn 9.8%
May 23, 2013
Investors eyeing a purchase of Regeneron Pharmaceuticals, Inc. (REGN) shares, but tentative about paying the going market price of $256.05/share, might benefit from considering selling puts among the... Read More
category Stocks
from Market News Video
Agree To Buy Regeneron Pharmaceuticals, Inc. At $165, Earn 9.8%
May 23, 2013
Investors eyeing a purchase of Regeneron Pharmaceuticals, Inc. (REGN) shares, but tentative about paying the going market price of $256.05/share, might benefit from considering selling puts among the... Read More
category Dividends
from Dividend Channel
iShares Nasdaq Biotechnology Index Fund Experiences Big Outflow
May 22, 2013
Symbols mentioned in this story: IBB, REGN, AMGN, CELG Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... Read More
category ETFs
from ETF Channel
UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changer
May 21, 2013
May 21 (Reuters) - A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for... Read More
category companyNews
from Reuters: Company News
Regeneron Pharmaceuticals Shares Up 53.7% Since SmarTrend's Buy Recommendation (REGN)
May 21, 2013
from Comtex SmarTrend® News Briefs
New Asthma Drug Generates Excitement For Patients -- And Its Maker
May 21, 2013
 Read More
category NYSE:MRK , NYSE:SNY , NASDAQ:REGN , and 1 more.
from Forbes Real Time
Sanofi (SNY), Regeneron (REGN) Report Publication of Positive Dupilumab Phase 2a Data
May 21, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8357210 for the full story. Read More
from StreetInsider.com News Articles
New Asthma Drug Could Be Game Changer
May 21, 2013
 Read More
category NYSE:SNY , NASDAQ:REGN , Hot Stocks
from InvestorPlace - Latest Headlines
Regeneron settles all pending litigation with Roche's Genentech
May 20, 2013
May 20 (Reuters) - Regeneron Pharmaceuticals Inc said it settled all pending litigation with Roche Holding AG's unit Genentech on the company's eye drug, Eylea, and cancer drug, Zaltrap. Read More
category companyNews
from Reuters: Company News
Regeneron (REGN) and Genentech Strike Deal on Worldwide EYLEA Sales
May 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8356010 for the full story. Read More
from StreetInsider.com News Articles
Earnings Look Back: Regeneron Pharmaceuticals Is Up 0.3% Since Reporting Quarterly Results 2 Weeks Ago (REGN)
May 20, 2013
from Comtex SmarTrend® News Briefs
< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here